We are live on ! Find out more
VECT

VectivBio Holding AG Ordinary Shares
VECT

Delisted

VECT was delisted on the 7th of July, 2023.

Back to rankings

2 hedge funds and large institutions have $520K invested in VectivBio Holding AG Ordinary Shares in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% less funds holding

Funds holding: 49 → 2 (-47)

98% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 48

100% less capital invested

Capital invested by funds: $504M → $520K (-$503M)

100% less funds holding in top 10

Funds holding in top 10: 7 → 0 (-7)

Holders
2
Holders Change
-47
Holders Change %
-95.92%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
48
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SOW
State of Wyoming
Wyoming
+$14.7K

Top Sellers

1
O
OrbiMed
New York
-$87.7M
2
TCM
TCG Crossover Management
California
-$52.9M
3
CA
CHI Advisors
New York
-$46.9M
4
VC
Vivo Capital
California
-$39.4M
5
GCL
Glazer Capital LLC
New York
-$31.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
BHMP
26
Bardin Hill Management Partners
New York
– -$2.77M -164,032 Closed
Millennium Management
27
Millennium Management
New York
– -$2.66M -157,606 Closed
KC
28
Kellner Capital
New York
– -$2.48M -145,597 Closed
NYLIM
29
New York Life Investment Management
New York
– -$2.28M -135,051 Closed
PMAM
30
Picton Mahoney Asset Management
Ontario, Canada
– -$1.7M -100,000 Closed
HHGC
31
Hunting Hill Global Capital
New York
– -$1.07M -63,581 Closed
Verition Fund Management
32
Verition Fund Management
Connecticut
– -$921K -54,620 Closed
AA
33
AQR Arbitrage
Connecticut
– -$888K -52,648 Closed
Renaissance Technologies
34
Renaissance Technologies
New York
– -$837K -49,600 Closed
HM
35
Harvest Management
New York
– -$779K -45,817 Closed
VF
36
Virtu Financial
New York
– -$699K -41,411 Closed
Geode Capital Management
37
Geode Capital Management
Massachusetts
– -$696K -41,274 Closed
WMSA
38
Weiss Multi-Strategy Advisers
New York
– -$627K -37,139 Closed
WP
39
Woodline Partners
California
– -$571K -33,827 Closed
WAM
40
Wolverine Asset Management
Illinois
– -$564K -33,426 Closed
GH
41
GAM Holding
Switzerland
– -$465K -27,545 Closed
DC
42
Diametric Capital
Massachusetts
– -$363K -21,500 Closed
CG
43
Carmignac Gestion
France
– -$340K -19,997 Closed
GC
44
Guggenheim Capital
Illinois
– -$262K -15,528 Closed
HF
45
HRT Financial
New York
– -$197K -11,695 Closed
ETC
46
Exchange Traded Concepts
Oklahoma
– -$144K -8,512 Closed
Citadel Advisors
47
Citadel Advisors
Florida
– -$22K -1,306 Closed
TRCT
48
Tower Research Capital (TRC)
New York
– -$3.12K -185 Closed
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
– -$2K -135 Closed
Morgan Stanley
50
Morgan Stanley
New York
– -$523 -31 Closed
1
2

VECT Hedge Fund Activity: Q3 2023 in Review

2 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in VectivBio Holding AG Ordinary Shares (VECT) for Q3 2023, worth a combined $520K — down 100% from $504M a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of VECT and 1 opened new positions — a net loss of 47 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was State of Wyoming, opening a new position worth an estimated $14.7K. The largest seller was OrbiMed, exiting entirely with an estimated $87.7M sold.

  • 2 institutional investors held VectivBio Holding AG Ordinary Shares (VECT) as of Q3 2023, down from 49 in Q2 2023.
  • Funds reported $520K of VectivBio Holding AG Ordinary Shares stock for Q3 2023, down 100% quarter-over-quarter.
  • 1 fund opened new VectivBio Holding AG Ordinary Shares positions in Q3 2023 and 48 closed out, a net change of -47 holders.
  • The largest VectivBio Holding AG Ordinary Shares buyer in Q3 2023 was State of Wyoming, an estimated $14.7K added.
  • The largest VectivBio Holding AG Ordinary Shares seller in Q3 2023 was OrbiMed, an estimated $87.7M sold.

Based on aggregated 13F filings for Q3 2023.